B. Schwartz

692 total citations
23 papers, 507 citations indexed

About

B. Schwartz is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. Schwartz has authored 23 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. Schwartz's work include Lung Cancer Treatments and Mutations (4 papers), Glycosylation and Glycoproteins Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). B. Schwartz is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Glycosylation and Glycoproteins Research (3 papers) and HER2/EGFR in Cancer Research (3 papers). B. Schwartz collaborates with scholars based in Israel, United States and Germany. B. Schwartz's co-authors include Sergio A. Lamprecht, Robert S. Bresalier, Young S. Kim, Sylvie Polak‐Charcon, Carmel Avivi-Green, Molly McGorry, Lisa E. Goehler, Monika Fleshner, David Martin and Steven F. Maier and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

B. Schwartz

22 papers receiving 498 citations

Peers

B. Schwartz

ONCOL

IMMUN

EPIDE

NEURO

Yongwei Qin China

Teresa Granato Italy

Fabienne Vavasseur France

Fumitaka Sato United States

Eleonora Piras Italy

Jeff Chang United States

Junxian Zhang China

Laura Collins United States

Meggan Czapiga United States

Jasleen Shant United States

Yongwei Qin China

B. Schwartz

237 ×1.1

80 ×0.8

ONCOL

169 ×2.0

IMMUN

97 ×1.2

EPIDE

87 ×1.3

NEURO

Citations per year, relative to B. Schwartz B. Schwartz (= 1×) peers Yongwei Qin

Countries citing papers authored by B. Schwartz

Since Specialization

Citations

This map shows the geographic impact of B. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Schwartz more than expected).

Fields of papers citing papers by B. Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Schwartz. The network helps show where B. Schwartz may publish in the future.

Co-authorship network of co-authors of B. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of B. Schwartz. A scholar is included among the top collaborators of B. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Schwartz. B. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Savage, Ronald E., Thomas C. Hall, & B. Schwartz. (2014). 145 ARQ 087, a novel pan FGFR-inhibitor crosses the BBB (blood–brain barrier) and distributes to the brain of rats. European Journal of Cancer. 50. 50–50. 1 indexed citations

Vinh, Donald C., B. Schwartz, Amy P. Hsu, et al.. (2011). Interleukin-12 Receptor 1 Deficiency Predisposing to Disseminated Coccidioidomycosis. Clinical Infectious Diseases. 52(4). e99–e102. 70 indexed citations

Laux, Isett, J M Goldman, B. Schwartz, et al.. (2009). Phase I dose escalation trial (ARQ 197–111) evaluating combination of selective c-Met inhibitor ARQ 197 and erlotinib. Journal of Clinical Oncology. 27(15_suppl). 3549–3549. 22 indexed citations

Awada, Ahmad, Alain Hendlisz, Thierry Gil, et al.. (2004). 381 A phase I study of BAY 43-90006, a novel Raf kinase and VEGFR inhibitor, in combination with taxotere in patients with advanced solid tumors. European Journal of Cancer Supplements. 2(8). 114–114. 7 indexed citations

Schoenfeld, Mircea Ariel, et al.. (2003). Clinical criteria for the switch of treatment strategies in Parkinson's disease. Clinical Neurology and Neurosurgery. 105(4). 241–244. 1 indexed citations

Schwartz, B., et al.. (2001). Adsorption of Cationized Bovine Serum Albumin onto Epithelial Crypt Fractions of the Rat Colon. Journal of Pharmaceutical Sciences. 90(10). 1516–1522. 4 indexed citations

Hegele, R A, et al.. (2001). CAVEAT: A comparison of cerivastatin 0.4 mg and 0.8 mg with atorvastatin 10 mg and 20 mg in patients with combined (type IIB) dyslipidaemia. Atherosclerosis Supplements. 2(2). 48–48. 4 indexed citations

Schwartz, B., et al.. (2000). A Protective Role of Dietary Vitamin D₃in Rat Colon Carcinogenesis. Nutrition and Cancer. 38(1). 65–73. 34 indexed citations

Fleshner, Monika, Lisa E. Goehler, B. Schwartz, et al.. (1998). Thermogenic and corticosterone responses to intravenous cytokines (IL-1β and TNF-α) are attenuated by subdiaphragmatic vagotomy. Journal of Neuroimmunology. 86(2). 134–141. 101 indexed citations

10.

Schwartz, B., Carmel Avivi-Green, & Sylvie Polak‐Charcon. (1998). Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. PubMed. 188(1-2). 21–30. 71 indexed citations

11.

Fraser, Gerald, Markus Bleich, D. Ecke, et al.. (1997). Characterization of sodium and chloride conductances in preneoplastic and neoplastic murine colonocytes. Pflügers Archiv - European Journal of Physiology. 434(6). 801–808. 11 indexed citations

12.

Niv, Yael, et al.. (1997). Gastrin levels in colorectal cancer.. PubMed. 33(3). 186–9. 7 indexed citations

13.

Niv, Yaron, B. Schwartz, Yoram Amsalem, & Sergio A. Lamprecht. (1996). Human HT-29 colon carcinoma cells: mucin production and tumorigenicity in relation to growth phases.. PubMed. 15(5B). 2023–7. 10 indexed citations

14.

Bresalier, Robert S., B. Schwartz, Young S. Kim, et al.. (1995). The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells.. PubMed. 55(11). 2476–80. 32 indexed citations

15.

Schwartz, B., et al.. (1995). Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.. PubMed. 15(1). 211–8. 6 indexed citations

16.

Schwartz, B., Robert S. Bresalier, & Young S. Kim. (1992). The role of mucin in colon‐cancer metastasis. International Journal of Cancer. 52(1). 60–65. 60 indexed citations

17.

Schwartz, B., et al.. (1991). Isolation and characterization of normal and neoplastic colonic epithelial cell populations. Gastroenterology. 100(3). 692–702. 30 indexed citations

18.

Schwartz, B., et al.. (1991). Characterization of tyrosine protein kinase associated with subcellular components of human colonic epithelium.. PubMed. 10(6). 1747–53. 2 indexed citations

19.

Schwartz, B., et al.. (1990). Growth-related enzyme activities in crypt compartments during rat colon carcinogenesis.. PubMed. 10(3). 773–8. 11 indexed citations

20.

Schwartz, B., et al.. (1988). Differential distribution of protein kinases along the crypt-to-lumen regions of rat colonic epithelium.. Gut. 29(9). 1213–1221. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact